TRIDENT LIFELINE
Back to Cashflow Statement
|
TRIDENT LIFELINE Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-10 Cr | ₹2.23 Cr | ₹-19 Cr | ₹-0.21 Cr |
What is the latest Cash Flow from Operating Activities ratio of TRIDENT LIFELINE ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-10 Cr |
| Mar2024 | ₹2.23 Cr |
| Mar2023 | ₹-19 Cr |
| Mar2022 | ₹-0.21 Cr |
How is Cash Flow from Operating Activities of TRIDENT LIFELINE Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-10 Cr | Negative | |
| Mar2024 | ₹2.23 Cr | Positive | |
| Mar2023 | ₹-19 Cr | Negative | |
| Mar2022 | ₹-0.21 Cr | - | |
Compare Cash Flow from Operating Activities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹307.6 Cr | -2.1% | -2.1% | -7.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -2.1% |
-2.1% |
-7.5% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses